127 related articles for article (PubMed ID: 24358756)
21. Protein engineering of antibodies.
Sandhu JS
Crit Rev Biotechnol; 1992; 12(5-6):437-62. PubMed ID: 1423650
[TBL] [Abstract][Full Text] [Related]
22. Antibody engineering and therapeutics conference. The annual meeting of the antibody society, Huntington Beach, CA, December 7-11, 2014.
Larrick JW; Parren P; Huston JS; Plückthun A; Bradbury A; Tomlinson IM; Chester KA; Burton DR; Adams GP; Weiner LM; Scott JK; Alfenito MR; Veldman T; Reichert JM
MAbs; 2014; 6(5):1115-23. PubMed ID: 25517297
[TBL] [Abstract][Full Text] [Related]
23. The role of glucan in the prevention and modification of microparasitic diseases.
Di Luzio NR; Williams DL
Prog Clin Biol Res; 1984; 161():443-56. PubMed ID: 6435131
[No Abstract] [Full Text] [Related]
24. Gene technologies for antibody engineering.
Winter G
Behring Inst Mitt; 1990 Dec; (87):10-20. PubMed ID: 2096816
[No Abstract] [Full Text] [Related]
25. [Chemotherapy for severe parasitic diseases].
Auzépy P
Rev Prat; 1991 Feb; 41(6):545-6. PubMed ID: 2020819
[No Abstract] [Full Text] [Related]
26. [The approaches of the Russian school of parasitologists and immunologists to the therapy of parasitic diseases].
Ozeretskovskaia NN
Med Parazitol (Mosk); 1998; (2):12-5. PubMed ID: 9691613
[No Abstract] [Full Text] [Related]
27. [Chemotherapy of parasitic diseases and immunodepression].
Ozeretskovskaia NN
Med Parazitol (Mosk); 1980; 49(5):3-12. PubMed ID: 6999322
[No Abstract] [Full Text] [Related]
28. [Current progress in parasitic immunology].
Capron A; Camus D
Brux Med; 1978 Oct; 58(10):525-31. PubMed ID: 82470
[No Abstract] [Full Text] [Related]
29. Tailor-made antibody therapeutics.
Chowdhury PS; Wu H
Methods; 2005 May; 36(1):11-24. PubMed ID: 15848071
[TBL] [Abstract][Full Text] [Related]
30. Human antibodies as next generation therapeutics.
van Dijk MA; van de Winkel JG
Curr Opin Chem Biol; 2001 Aug; 5(4):368-74. PubMed ID: 11470598
[TBL] [Abstract][Full Text] [Related]
31. Antibodies and genetically engineered related molecules: production and purification.
Roque AC; Lowe CR; Taipa MA
Biotechnol Prog; 2004; 20(3):639-54. PubMed ID: 15176864
[TBL] [Abstract][Full Text] [Related]
32. Clinical issues in antibody design.
Chester KA; Hawkins RE
Trends Biotechnol; 1995 Aug; 13(8):294-300. PubMed ID: 7662305
[TBL] [Abstract][Full Text] [Related]
33. The application of transgenic mice for therapeutic antibody discovery.
Lee EC; Owen M
Methods Mol Biol; 2012; 901():137-48. PubMed ID: 22723098
[TBL] [Abstract][Full Text] [Related]
34. Humanized antibodies as potential therapeutic drugs.
Vaswani SK; Hamilton RG
Ann Allergy Asthma Immunol; 1998 Aug; 81(2):105-15; quiz 115-6, 119. PubMed ID: 9723555
[TBL] [Abstract][Full Text] [Related]
35. Engineering of therapeutic antibodies to minimize immunogenicity and optimize function.
Presta LG
Adv Drug Deliv Rev; 2006 Aug; 58(5-6):640-56. PubMed ID: 16904789
[TBL] [Abstract][Full Text] [Related]
36. Application of monoclonal antibodies in tropical diseases research.
Tharavanij S
Southeast Asian J Trop Med Public Health; 1984 Sep; 15(3):371-84. PubMed ID: 6084305
[No Abstract] [Full Text] [Related]
37. Antibody production without animals.
Stadler BM
Dev Biol Stand; 1999; 101():45-8. PubMed ID: 10566774
[TBL] [Abstract][Full Text] [Related]
38. Serodiagnosis of tropical parasitic diseases with special reference to the standardization of labelled reagent tests.
Voller A
Dev Biol Stand; 1985; 62():3-9. PubMed ID: 3914425
[No Abstract] [Full Text] [Related]
39. Effect of anti-interferon antibody on infections of animals.
Fauconnier B
Tex Rep Biol Med; 1981-1982; 41():522-5. PubMed ID: 6189217
[No Abstract] [Full Text] [Related]
40. [Generation of genetic engineering anti-idiotypic antibody against OC125 monoclonal antibody of ovarian carcinoma].
Zhang X; Cui H; Qian H
Zhonghua Fu Chan Ke Za Zhi; 1996 Nov; 31(11):646-8. PubMed ID: 9387521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
